Calendar Eiger BioPharmaceuticals
Stocks
EIGR
US28249U2042
Biotechnology & Medical Research
|
Market Closed -
OTC Markets
11:27:07 2024-09-27 EDT
|
5-day change | 1st Jan Change | ||
| 8.500 USD | -.--% |
|
-.--% | - |
| 24-10-01 | Eiger BioPharmaceuticals Files for Chapter 11 Bankruptcy as Liquidation Plan Takes Effect | CI |
| 24-09-30 | Eiger BioPharmaceuticals, Inc. Went Out of Business | CI |
Upcoming events on Eiger BioPharmaceuticals
No events available
Past events on Eiger BioPharmaceuticals
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 12,1 12,4 -2.34% | 13,5 15,2 -11.26% | 15,8 18,4 -14.5% |
|
EBITDA Million USD | Released Forecast Spread | -76,7 -77,6 1.25% | -92,4 -92,2 -0.22% | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -76,9 -77,5 0.71% | -92,7 -92,1 -0.69% | -71,8 -69,9 -2.75% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -33,9 -46,6 27.41% | -96,8 -96,6 -0.13% | -75,0 -72,8 -3.03% |
|
Net income Million USD | Released Forecast Spread | -33,9 -46,7 27.33% | -96,8 -96,7 -0.12% | -75,0 -72,8 -3.03% |
|
EPS USD | Released Forecast Spread | -30,0 -40,7 26.34% | -69,6 -67,3 -3.46% | -50,8 -49,2 -3.21% |
| Announcement Date | 10/03/22 | 17/03/23 | 08/04/24 |
Quarterly results
| Fiscal Period | December | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 4,09 5,08 -19.41% | 4,02 4,26 -5.5% | 2,70 4,42 -39.03% | 4,12 3,82 7.74% | 4,64 4,57 1.63% | 3,21 4,91 -34.65% | 3,80 6,48 -41.3% |
|
EBIT Million USD | Released Forecast Spread | -20,1 -21,0 4.61% | -26,4 -21,8 -20.86% | -24,5 -23,7 -3.12% | -22,3 -20,2 -10.07% | -20,0 -18,1 -10.33% | -16,9 -12,9 -30.77% | -12,6 -10,7 -17.93% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -21,9 -22,1 1.27% | -27,1 -22,8 -18.93% | -25,1 -24,7 -1.77% | -22,8 -21,0 -8.65% | -20,7 -18,6 -11.52% | -18,0 -13,4 -34.41% | -13,5 -11,2 -19.59% |
|
Net income Million USD | Released Forecast Spread | -21,9 -22,2 1.21% | -27,1 -22,8 -18.9% | -25,1 -24,7 -1.75% | -22,8 -21,0 -8.66% | -20,7 -18,6 -11.53% | -18,0 -13,4 -34.41% | -13,5 -11,2 -19.61% |
|
EPS USD | Released Forecast Spread | -15,3 -18,7 18.18% | -18,6 -15,6 -19.23% | -16,8 -16,1 -4.19% | -15,6 -13,4 -16.85% | -14,1 -11,6 -22.08% | -12,3 -9,15 -34.43% | -8,78 -7,50 -17.07% |
| Announcement Date | 04/08/22 | 03/11/22 | 17/03/23 | 11/05/23 | 14/08/23 | 09/11/23 | 08/04/24 |
| 2026-08-26 |  | Board of Directors Meeting | |
| Today | | Earnings release - Q2 2026 | |
| Today | | Earnings presentation | 03:30 |
| Today | | Earnings release - Q2 2026 | 02:00 |
| Today | | Présentation aux Actionnaires / Analystes | 03:30 |
| Today | | Annual General Meeting | 03:30 |
| Today | | Earnings release - Annual 2026 | |
| 2026-08-26 | | Earnings presentation | 18:30 |
| Today | | Earnings release - Q2 2026 | |
| 2026-08-26 | | Board of Directors Meeting |
Past sector events for Eiger BioPharmaceuticals
| Today | | Board of Directors Meeting | |
| Today | | Board of Directors Meeting | |
| 2026-08-25 | | Earnings release - Q2 2026 | |
| 2026-08-25 | | Présentation aux Actionnaires / Analystes | 02:00 |
| 2026-08-25 | | Annual General Meeting | 02:00 |
| 2026-08-24 | | Ex-dividend date - 0.08 USD | 00:00 |
| 2026-08-24 | | Earnings release - Q2 2026 | |
| 2026-08-24 | | Board of Directors Meeting | |
| 2026-08-20 | | Earnings release - Q2 2026 | 03:00 |
| 2026-08-20 | | Earnings release - Q2 2026 |
- Stock Market
- Stocks
- EIGR Stock
- Calendar Eiger BioPharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
